ALBANY, N.Y., Jan. 4, 2016 /PRNewswire/ -- Albany Molecular
Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief
Executive Officer, will present at the 34th Annual J.P. Morgan
Healthcare Conference on Thursday, January
14, 2016 at 7:30 a.m. PT, with
a question and answer session to follow at 8:00 a.m. PT. A live audio webcast of the
presentation and question and answer session can be accessed at
AMRI's Investor Relations web site at
http://ir.amriglobal.com/events.cfm?CalendarID=2
The webcast will be archived for 90 days following the live
presentation.
About AMRI
Albany Molecular Research Inc. (AMRI) is a
global contract research and manufacturing organization that has
been working with the Life Sciences industry to improve patient
outcomes and the quality of life for more than two decades. With
locations in North America,
Europe and Asia, our key business segments include
Discovery and Development Solutions (DDS), Active Pharmaceutical
Ingredients (API), and Drug Product Manufacturing (DPM). Our DDS
segment provides comprehensive services from hit identification to
IND, including expertise with diverse chemistry, library design and
synthesis, in vitro biology and pharmacology, drug metabolism and
pharmacokinetics, as well as natural products. API supports the
chemical development and cGMP manufacture of complex API, including
potent, controlled substances, biologics, peptides, steroids,
hormones, cytotoxic compounds and sterile API. DPM supports
development through commercial scale production of complex
liquid-filled and lyophilized parenterals, sterile suspensions and
ophthalmic formulations. For more information about AMRI, please
visit our website at www.amriglobal.com or follow us on Twitter
(@amriglobal).
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/amri-ceo-to-present-at-the-34th-annual-jp-morgan-healthcare-conference-300197557.html
SOURCE AMRI